Sun Pharmaceutical Company Profile

Aggregated data from the web about Sun Pharmaceutical

Company Name	Sun Pharmaceutical
Website	https://sunpharma.com
Snippet	Jul 11, 2022 · The Sun Story. Watch the inspiring growth story of Sun – from humble beginnings in 1983 with just 2 employees and 5 psychiatry products to becoming the 4th largest global generic pharmaceutical company, selling over 2000 products in over 100 countries.
ISIN	INE044A01036
Type	Public
Founded	1983
Founder	Dilip Shanghvi
Revenue	₹334,734 million (US$4.7 billion) (2020)[1]
Website	www.sunpharma.com
Industry	Pharmaceuticals
Products	Pharmaceuticals, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health
Traded as	BSE: 524715, NSE: SUNPHARMA, BSE SENSEX Constituent, NSE NIFTY 50 Constituent
Key people	Dilip Shanghvi (CEO)
Net income	₹37,649 million (US$530 million) (2020)[1]
Area served	Worldwide
Headquarters	Mumbai, Maharashtra, India
Total assets	₹682,524 million (US$9.6 billion) (2020)[1]
Total equity	₹491,246 million (US$6.9 billion) (2020)[1]
Operating income	₹50,095 million (US$700 million) (2020)[1]
Number of employees	36,000 (2020)[1]

Sun Pharmaceutical is part of the India company list

Sun Pharmaceutical is part of the Pharmaceuticals company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.